<== Site of the Week for 2015-12-18 ==>
Established in 1995, GlobeImmune is a Louisville based pharmaceutical developing treatments for infectious diseases and cancer with its Tarmogen® immunotherapy platform.
The company raised $17.5M in a public offering in January 2010. They trade on NASDAQ with the symbol GBIM.
The video below, with extremely poor audio, features the GlobeImmune CEO talking about doings in the pharmaceutical world and the roll that small research companies play in the works.